← The Wire
TGTXNasdaq
TG THERAPEUTICS, INC.
Pharmaceutical Preparations · DE · CIK 1001316
Develops and commercializes novel treatments for B-cell diseases, including approved multiple sclerosis therapy BRIUMVI
⚡ Elevated coverage
$7.58B
Market cap
$55.72
Last close
-0.2%
1D
+2.4%
5D
2.1M
Volume
Price · last 39 sessions+56.1%
May 4L $35.70 · H $55.83Jun 29
403
Total filings
Jun 12, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 12, 20268-KCompany UpdateJun 3, 20268-KCompany UpdateMay 27, 202610-QFORM 10-QMay 6, 20268-KResults of OperationsMay 6, 2026DEF 14AFORM DEF 14AApr 30, 20268-KMaterial Agreement · New Debt / ObligationMar 20, 202610-KFORM 10-KFeb 27, 20268-KResults of OperationsFeb 26, 20268-KReg FD DisclosureJan 13, 202610-QFORM 10-QNov 5, 20258-KResults of OperationsNov 3, 202510-QFORM 10-QAug 8, 20258-KResults of OperationsAug 4, 20258-KShareholder VoteJun 13, 202510-QFORM 10-QMay 9, 20258-KResults of OperationsMay 5, 2025DEFA14AFORM DEFA14AApr 30, 2025DEF 14AFORM DEF 14AApr 30, 202510-KFORM 10-KMar 3, 20258-KResults of OperationsMar 3, 20258-KReg FD DisclosureJan 14, 202510-QFORM 10-QNov 7, 20248-KResults of OperationsNov 4, 202410-QFORM 10-QAug 9, 202410-K/AFORM 10-K/AAug 9, 20248-KMaterial Agreement · Agreement TerminatedAug 6, 20248-KExecutive Change · Bylaw AmendmentJun 17, 202410-QFORM 10-QMay 6, 20248-KResults of OperationsMay 1, 2024DEFA14AFORM DEFA14AApr 29, 2024DEF 14AFORM DEF 14AApr 29, 202410-KFORM 10-KFeb 29, 20248-KResults of OperationsFeb 28, 20248-KMaterial Agreement · Reg FD DisclosureJan 10, 202410-QFORM 10-QNov 6, 20238-KResults of OperationsNov 1, 202310-Q10-QAug 4, 20238-KMaterial Agreement · Results of OperationsAug 1, 20238-KShareholder VoteJun 15, 202310-Q10-QMay 8, 2023DEFA14ADEFA14AMay 1, 2023DEF 14ADEF 14AMay 1, 20238-KResults of OperationsMay 1, 2023SC 13GTG THERAPEUTICS, INC.Apr 3, 202310-K10-KMar 1, 20238-KResults of OperationsFeb 28, 20238-KCompany UpdateDec 28, 20228-KResults of OperationsNov 10, 202210-Q10-QNov 9, 202210-Q10-QAug 9, 20228-KResults of OperationsAug 8, 20228-KShareholder VoteJun 23, 202210-Q10-QMay 10, 2022DEFA14ADEFA14AApr 29, 2022DEF 14ADEF 14AApr 29, 20228-KCompany UpdateApr 18, 202210-K10-KMar 1, 20228-KResults of OperationsMar 1, 20228-KCompany UpdateJan 27, 20228-KMaterial AgreementJan 4, 20228-KCompany UpdateNov 30, 202110-Q10-QNov 8, 20218-KResults of OperationsNov 4, 202110-Q10-QAug 6, 20218-KResults of OperationsAug 2, 20218-KExecutive ChangeJun 23, 20218-KBylaw Amendment · Shareholder VoteJun 21, 202110-Q10-QMay 10, 20218-KResults of OperationsMay 10, 2021DEFA14ADEFA14AApr 30, 2021DEF 14ADEF 14AApr 30, 20218-KCompany UpdateApr 16, 20218-KAuditor ChangeApr 13, 20218-KResults of OperationsMar 2, 202110-K10-KMar 1, 2021SC 13GSCHEDULE 13GFeb 10, 20218-KCompany UpdateFeb 8, 20218-KMaterial AgreementDec 16, 2020424B5424B5Dec 16, 2020
Insider Activity
In the 90 days to Nov 24, 2025: 1 sold $163K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 24, 2025 | Echelard YannDirector | Sell | 5,000 | $32.57 | $163K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
⚡ Elevated coverageCoverage (30d): 4 reputable articles.
Investor's Business DailyThe Utter Rampage That Sent This Biotech Flying 70%12d agoInvestor's Business DailyStock Of The Day Breaks Out; What The CEO Said To Drive It19d agoInvestor's Business DailyStock Market Today: Indexes Whipsaw Around Key Levels; TG Therapeutics, Enova, Bloom Energy In Focus20d agoInvestor's Business DailyTG Therapeutics Flashes An Early Buy Signal — What Drove The Bullish Jump27d agoInvestor's Business DailyMultiple Sclerosis-Focused Biotech Quadruples Its Profit, Raises Sales Forecast1mo ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance